Teva Pharmaceuticals

By root | February 26, 2006 AAA

On February 22 we mentioned that the Biotech HOLDRs ETF was trading within a descending channel and that it would be interesting to see if it could head higher. As you can see from the chart below, the bulls were able to push BBH above the trendline today, which is now being used by traders to confirm buying opportunities found in other biotech stocks. For example, as you can see from the chart of TEVA (lower chart), it has also broken above the upper resistance of a descending trendline and now looks like it will go higher.

We've also added the MACD to the chart of TEVA, which has recently crossed above its signal line. This bullish crossover will also be used by the bulls as confirmation of further upward momentum

BBH_022706.jpg
TEVA_022706.jpg

You May Also Like

Related Analysis
  1. Investing

    Risks and Rewards of Biotech Companies

  2. Stock Analysis

    FireEye Shows Evidence That Profits Are Possible

  3. Stock Analysis

    When Will Celgene's Key Patents Expire?

  4. Stock Analysis

    Why Do Investors Want Intel to Get Bigger?

  5. Stock Analysis

    Micron Technology: Big Bargain or Value Trap?

Trading Center